Clinical Trial Update: Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sacubitril-valsartan to usual antihypertensives in patients with congestive heart failure and hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Congestive Heart Failure, Hypertension | Phase 4 | Status: WITHDRAWN